Clinical Report: Oromandibular Dystonia Resistant to Botulinum Toxin
Background
Oromandibular dystonia (OMD) is a focal dystonia affecting the muscles of mastication and facial expression, often treated with botulinum toxin injections. However, non-response to this treatment may indicate misdiagnosis or the presence of structural disorders, such as long-standing condylar dislocation, which can mimic OMD symptoms. Understanding these distinctions is crucial for appropriate management and treatment.
Data Highlights
No numerical data or trial data were presented in the article.
Key Findings
Two cases of patients diagnosed with OMD showed no improvement after botulinum toxin injections.
Subsequent evaluations revealed long-standing condylar dislocation as the primary diagnosis.
Both patients experienced significant improvement following structural correction and prosthetic rehabilitation.
Botulinum toxin non-response should prompt a systematic reassessment of the diagnosis in suspected OMD cases.
Features such as fixed mandibular deviation and impaired closure may indicate the need for structural evaluation.
Clinical Implications
Clinicians should consider structural disorders like condylar dislocation in patients with OMD-like symptoms who do not respond to botulinum toxin therapy. A thorough dental and oral/maxillofacial evaluation is recommended before continuing with chemodenervation in such cases.
Conclusion
These cases illustrate the importance of reassessing the diagnosis of OMD in patients who do not respond to standard treatments, highlighting the potential for misdiagnosis of structural conditions.
